United States: Trove Of SNF Claims Data Released By CMS – Ready For Mining By Auditors And Whistleblowers

Last Updated: May 9 2016
Article by Aaron Buchman and Brian T. McGovern

Most Read Contributor in United States, September 2017

Over recent years, the Federal government has trained its sights on potential billing abuses in the Medicare Part A program for Skilled Nursing Facilities ("SNFs") in the provision of rehabilitation therapy services.  The U.S. Health and Human Services Office of the Inspector General ("OIG") issued a report in September 2015, finding that the current methodology "creates a strong financial incentive for SNFs to bill for higher levels of therapy even when beneficiaries do not need such levels."1  The OIG recommended that the Centers for Medicare & Medicaid Services ("CMS") restructure the payment system to address "longstanding concerns" over "the method of paying for therapy."2  Just last month, OIG underscored the priority of replacing the current SNF payment system by identifying the reevaluation and replacement as one of its top 25 unimplemented recommendations for CMS.3  The OIG reiterated another of its core findings, that "Medicare payments for therapy greatly exceeded SNFs' costs for therapy." 

Earlier last month, the Medicare Payment Advisory Commission ("MedPAC") voted to recommend that CMS establish a "site neutral" prospective payment system for reimbursing nursing homes, home health agencies, and rehabilitation hospitals for post-acute care services that is based on medical acuity, rather than the setting where care is delivered.4

Meanwhile, CMS has initiated several demonstrations and initiatives to tie nursing home payment to quality performance, to broaden bundled payments, and generally to incentivize facilities and other providers to better coordinate post-acute care and contain costs.  As CMS explores alternative models for reimbursing SNFs, CMS along with OIG and the U.S. Department of Justice continues to focus enforcement attention on the billions of dollars allegedly over-billed under the existing model.

CMS Releases Data to Highlight Suspicious Therapy Billing

CMS has now made it easier for RACs and other government auditors -- as well as whistleblowers -- to target SNFs that bill Medicare for residents receiving therapy at higher rates than its peers.  On March 9, 2016, CMS released a Public Use File ("PUF") of data on Medicare claims and payments to SNFs during 2013,5 allowing the public to get a granular view of each SNF's billing practices, including RUG scores and associated therapy minutes for their rehabilitation residents.  With this data, CMS has given auditors and False Claims Act ("FCA")6 lawyers alike the ability to target potentially vulnerable SNFs and, in the case of FCA counsel, to recruit current or former employees to serve as qui tam relators against potential SNF defendants. 

The PUF includes the names and addresses of SNFs; lists the number of resident-days, number of residents, and reimbursement level; and specifies the amounts that the SNF charged, and that CMS allowed and ultimately paid. The PUF breaks down the billing data by Resource Utilization Group (RUG).  The current RUG system classifies nursing home residents into 66 different RUG categories based on the level of care provided to the resident, including assistance with activities of daily living and prescribed rehabilitation therapy.  The higher the RUG score, the higher the per diem rate. 

The PUF focuses on the RUG scores for SNF residents receiving either "Very High" or "Ultra High" levels of rehabilitation therapy.7 These categories are distinguished by clearly delineated thresholds, or cutoffs, of therapy minutes that a resident receives. For instance, an Ultra High therapy score requires that a resident receive a minimum of 720 minutes of therapy over a 7-day assessment period, while residents receiving between 500 and 719 minutes of therapy are classified in the Very High RUG. A resident receiving 499 or fewer minutes of therapy would be reimbursed at the still lower rate for the "High" RUG category.  Regulators and other authorities have observed that, although only a single minute of therapy might distinguish the services being provided to two otherwise clinically identical nursing home residents, the resident receiving the extra minute of therapy accrues a higher rate for the SNF, by as much as $160 per day.8  The rate differential can translate into potentially thousands of additional Medicare dollars over the course of a SNF stay.  Hence, over-treatment (or over-reporting) for therapy, beyond a resident's medical needs, would inflate a SNF's RUG scores and yield higher payments by CMS.

Where one might expect SNF residents to be prescribed and actually receive a wide range of therapy levels, CMS has in fact found a pattern of SNFs reporting that residents received therapy in amounts that barely exceed the thresholds for the given therapy level. Nationwide, 65% of residents classified in the Ultra High RUG categories received 720 to 730 minutes of therapy, and 51% of residents in the Very High RUG received 500 to 510 minutes.9

CMS views the pattern of consistently providing therapy within 10 minutes of the minimum levels as particularly concerning.  In the PUF release fact sheet, CMS counted 88 out of 15,055 SNFs that had classified all of their Very High RUG residents based on providing 510 or fewer minutes of therapy.10  215 SNFs had classified all Ultra High residents based on 730 or fewer therapy minutes.11  For over 1,000 SNFs, 95% or more of their Ultra High or Very High RUG residents were classified into those categories based on a near-threshold amounts of therapy.12 The names and addresses of each of these SNFs is readily found in the PUF data.

Risk of Government Scrutiny and FCA Liability

SNFs with the highest frequency of near-threshold RUGs are at heightened risk of scrutiny for improper "upcoding."  Upon the release of the PUF, CMS announced that near-threshold billing patterns "have prompted us to refer this issue to the Recovery Auditor Contractors (RAC) for further investigation."13  SNF operators also should expect the OIG and U.S. Department of Justice to examine the PUF data closely. 

In addition to RAC inquiries, SNFs may face claims by private parties seeking to recover monetary relief as whistleblowers under the FCA.  As noted, the PUF identifies both the frequency of near-threshold RUGs and the number and total value of claims at each RUG score.  Armed with that information, relator counsel can determine which facilities might be most vulnerable to allegations of excessive therapy billing and thereby exposed to potential FCA liability.

A "suspect" billing pattern identified in the PUF data does not alone support a claim of FCA liability. To be viable, an FCA claim requires, among other things, a showing that the defendant made or submitted a false claim either knowing it was false, or with reckless disregard or deliberate ignorance of the validity of the claim.14 The PUF does not offer any theories or insights into the "how or why" for such frequent near-threshold RUGs scoring.  However, the community of qui tam attorneys could mine the PUF data to target vulnerable SNFs for possible litigation, and try to identify and recruit potential relators to allege the requisite detail about a facility's billing practices to make out an FCA claim. 

Takeaways

With the PUF data now in the public domain, it would be prudent for SNFs to examine the data for themselves, before a RAC auditor or government investigator begins a formal inquiry.  Some of the steps to consider include:

  • Reviewing the PUF data in conjunction with other resources, such as PEPPER reports, to see if the data suggest any concerning billing practices. 
  • Assessing whether those practices point to any systemic lapse in billing protocols or compliance, and undertaking appropriate remedial action, which might include in-service training, revisions to procedures or protocols for therapy evaluations, or employment actions against non-compliant staff.
  • Evaluating whether practices warrant a retrospective review of claims, refund, or self-disclosure.
  • Consulting compliance counsel if any of the foregoing points to a risk of FCA liability.

Footnotes

1 Department of Health and Human Services, Office of Inspector General, "The Medicare Payment System for Skilled Nursing Facilities Needs to Be Reevaluated," September 2015, available at http://www.oig.hhs.gov/oei/reports/oei-02-13-00610.pdf.

2 Id.

3 Department of Health and Human Services, Office of Inspector General, "Compendium of Unimplemented Recommendations," April 2016, available at http://oig.hhs.gov/reports-and-publications/compendium/files/compendium2016.pdf.

4 Elizabeth Leis Newman, McKnights News Service, "MedPAC Provides Roadmap for Post-Acute Care Overhaul," April 10, 2016, available at http://hhcfinance.com/news-and-resources/2016/04/10/medpac-provides-roadmap-for-post-acute-care-overhaul/.

5 The PUF is available at https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare-Provider-Charge-Data/SNF.html.

6 The FCA allows a private person (a "relator") to bring a civil lawsuit on behalf of the U.S. government (a "qui tam" action) against a defendant that has over-billed a government program through the submission of false claims. 31 U.S.C. §§ 3729, 3730(b).  Relators and their attorneys are entitled to a share of any recovery by the government as a result of their suit. 31 U.S.C. § 3730(d). Depending on whether the government "intervenes" to control the litigation or leaves the relator to fight the battle on its own, the relator is entitled to between 15% and 30% of the proceeds of the action or any settlement.

7 The RUG system subdivides Ultra High and Very High therapy each into 5 separate RUG scores based on the resident's care needs other than therapy: RUX, RUL, RUA, RUB, RUC for Ultra High and RVX, RVL, RVA, RVB, and RVC for Very High. The PUF contains data broken out by each RUG score separately, while other tables aggregate data by therapy level.

8 Author's calculation based on CMS base rates. Exact rates paid by CMS vary due to other resident characteristics and regional price adjustments. The Ultra High per diems exceed the corresponding Very High rates by 12% to 34%. The Very High per diems in turn exceed the corresponding High rates by 10% to 24%.

9 Press Release, "Medicare Skilled Nursing Facility (SNF) Transparency Data  (CY2013)" March 9, 2016, available at https://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-sheets/2016-Fact-sheets-items/2016-03-09.html.

10 Id.

11 Id.

12 Authors' calculation based on analysis of the PUF data. The PUF data may be sorted by the frequency of near-threshold RUGs among reimbursement claims for Very High and Ultra High residents.

13 Press Release, "CMS releases Skilled Nursing Facility utilization and payment data," March 9, 2016, available at https://www.cms.gov/Newsroom/MediaReleaseDatabase/Press-releases/2016-Press-releases-items/2016-03-09.html.

14 31 U.S.C. § 3729(a), (b)(1). If the PUF provided enough information to make an FCA claim, such a claim arguably would be barred as based on "substantially the same" allegations already subject to a public disclosure. 31 U.S.C. § 3730(e)(4)(A). "Congress has clearly stated that 'parasitic' actions based on publicly disclosed allegations of wrongdoing are not to be entertained." U.S. ex rel. Kester v. Novartis Pharm. Corp., 43 F. Supp. 3d 332, 345 (S.D.N.Y. 2014).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.